Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysisNafees Ahmad, Afrânio Lineu Kritski, Andrea Benedetti et al.|The Lancet|2018Cited by 639
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis NetworkGiovanni Battista Migliori, José-María García-García, Simon Tiberi et al.|International Journal of Infectious Diseases|2020Cited by 226
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global reportBorisov Se, Valentina Marchese, Edvardas Danila et al.|European Respiratory Journal|2019Cited by 176
Early COVID-19 pandemic’s toll on tuberculosis services, WHO European Region, January to June 2020Masoud Dara, Martin J. Boeree, Giorgi Kuchukhidze et al.|Eurosurveillance|2021Cited by 38
Factors Associated with Unfavourable Treatment Outcomes in Patients with Tuberculosis: A 16-Year Cohort Study (2005–2020), Republic of Karakalpakstan, UzbekistanJamshid Gadoev, Masoud Dara, Damin Asadov et al.|International Journal of Environmental Research and Public Health|2021Cited by 9